Safe Shipping Nootropics Coluracetam/Mkc231 Powder Samrt Research

[freemexy]

Safe Shipping Nootropics Coluracetam/Mkc231 Powder Samrt Research

Nootropics powder is a nootropic drug of the racetam family. Coluracetam was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California. Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose. It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.

Product name: Coluracetam
Also Known As
MKC-231, BCI-540, 2-(2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro2, 3-b quinolin-4-yl)acetoamide
Specification: 99%
CAS No.: 135463-81-9
Appearance: White powder
Molecular Formula: C19H23N3O3
Molecular Weight: 341.4042
The way coluracetam works and its chemical structure are very different to other racetams. Even though it is in the same family, this nootropic has developed a reputation as being a unique smart drug compared with others. Coluracetam is no less effective than other racetams, however.
Coluracetam is a fairly new nootropic compound, which is part of the racetam family. Because of how new it is, there are relatively few studies regarding the efficacy of the drug. Yet, what does exist is extremely promising for anyone interested in improving their memory, protecting their brain from neurological degeneration, and improving cognitive abilities.

The primary benefit of coluracetam is the increase in high affinity choline uptake (HACU). More specifically, this process helps increase the uptake of choline into the synapses of the brain in order to synthesize more acetylcholine. Usually, human brains have limitations on acetylcholine production and coluracetam bypasses this for your cognitive benefit.

The downstream effects of this are manifold. One of the main proposed coluracetam benefits is as a neuroprotective agent that can support against Alzheimer's disease [4]. While the research is still scarce, this seems plausible given the interactions with the cholinergic system and these age-related neurological diseases.

Anecdotal evidence suggests that coluracetam, like some of the other racetams, can act as a mood enhancer as well. This evidence comes through nootropic communities as many people take the drug for cognitive enhancement and note the secondary effects. View the Selected Community Experiences below to see how people are reacting to coluracetam itself.